Home » Anti Covid pill, Merck: “Reduced deaths and hospitalizations by 50%, soon request ok to Fda”

Anti Covid pill, Merck: “Reduced deaths and hospitalizations by 50%, soon request ok to Fda”

by admin

Merck accelerates the process to bring the Covid-19 treatment pill to market and challenges Pfizer. The pharmaceutical company has in fact published the first results of the trial which showed a 50% reduction in the risk of hospitalization and deaths of people infected with the coronavirus. Merck and partner Ridgeback Biotherapeutics have announced that they will soon ask the US FDA to authorize emergency use of the drug, molnupiravir, in the United States as soon as possible.

.

See also  ReiThera vaccine, 93% antibody response after the first dose

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy